Invention Application
WO2014074695A1 RETINOIC ACID ENHANCED HUMAN STEM CELL DERIVED BLOOD BRAIN BARRIER MODEL
审中-公开
反义酸增强人类干细胞衍生的血液脑屏障模型
- Patent Title: RETINOIC ACID ENHANCED HUMAN STEM CELL DERIVED BLOOD BRAIN BARRIER MODEL
- Patent Title (中): 反义酸增强人类干细胞衍生的血液脑屏障模型
-
Application No.: PCT/US2013/068914Application Date: 2013-11-07
-
Publication No.: WO2014074695A1Publication Date: 2014-05-15
- Inventor: SHUSTA, Eric, V. , PALECEK, Sean, P. , LIPPMANN, Ethan, S. , AZARIN, Samira, M.
- Applicant: WISCONSIN ALUMNI RESEARCH FOUNDATION , SHUSTA, Eric, V. , PALECEK, Sean, P. , LIPPMANN, Ethan, S. , AZARIN, Samira, M.
- Applicant Address: 614 Walnut Street Madison, WI 53705 US
- Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION,SHUSTA, Eric, V.,PALECEK, Sean, P.,LIPPMANN, Ethan, S.,AZARIN, Samira, M.
- Current Assignee: WISCONSIN ALUMNI RESEARCH FOUNDATION,SHUSTA, Eric, V.,PALECEK, Sean, P.,LIPPMANN, Ethan, S.,AZARIN, Samira, M.
- Current Assignee Address: 614 Walnut Street Madison, WI 53705 US
- Agency: LIU, Yonglin
- Priority: US61/724,072 20121108; US13/793,466 20130311
- Main IPC: C12N5/0797
- IPC: C12N5/0797 ; C12N5/071
Abstract:
In one embodiment, the present invention is a method of creating a fully-human blood-brain barrier (BBB) model, comprising the steps of (a) obtaining a mixture of neural cells and brain microvascular endothelial cells (BMECs), wherein the neural cells and BMECs that comprise the mixture were produced from the differentiation of human pluripotent stem cells (hPSCs); (b) purifying BMECs from the mixture of neural cells and BMECs of step (a); and (c) co-cuituring the purified BMECs with a ceil type selected from the group consisting of pericytes, astrocytes and differentiated neural progenitor ceils (NPCs), wherein a blood brain barrier model is created. In another embodiment the present invention is a method of creating a retinoic acid (RA)-enhanced or RA-like compound-enhanced mammalian blood-brain barrier (BBB) model, comprising the steps of: (a) obtaining a mixture of neural cells and brain microvascular endothelial ceils (BMECs) in the presence of RA or RA-like compound, wherein the mixture of neural ceils and BMECs was produced from the differentiation of human pluripotent stem ceils (hPSCs); (b) purifying BMECs from the mixture of neural cells and BMECs; and co- cuituring the purified BMECs with a cell type selected from the group consisting of astrocytes, pericytes and differentiated neural progenitor ceils (NPCs), wherein a BBB model is created.
Information query